Papers by Trevor Williams
Thorax, 1997
Bookmarks Related papers MentionsView impact
Thorax, 1997
Bookmarks Related papers MentionsView impact
The Journal of Thoracic and Cardiovascular Surgery, 2005
Bookmarks Related papers MentionsView impact
European Respiratory Journal, 1997
Lung transplantation is now an established therapeutic intervention for end-stage cardiopulmonary... more Lung transplantation is now an established therapeutic intervention for end-stage cardiopulmonary disease in humans. Chronic rejection, in the form of bronchiolitis obliterans syndrome (BOS), remains the commonest cause of morbidity and mortality in those surviving more than 3 months. The pathology of BOS involves airway changes. We have evaluated the potential for endobronchial biopsies (EBB) to complement existing sampling methods used in allograft monitoring and have compared the results of EBB findings with those of bronchoalveolar lavage (BAL) and transbronchial biopsy (TBB) in 18 clinically stable patients. We found that all the EBB had inflammatory cells present but that only five TBB specimens had evidence of inflammation, with airway material being present in 78% of the TBB. Paired BAL and EBB yielded different results, with no correlations between total macrophages, lymphocytes, CD4+ cells or CD8+ cells. We conclude that endobronchial biopsies are potentially useful as an ...
Bookmarks Related papers MentionsView impact
American Journal of Respiratory and Critical Care Medicine, 1999
Bookmarks Related papers MentionsView impact
European Journal of Heart Failure, 2012
The impact of cardiac dysfunction on the liver is known as cardiac hepatopathy. In certain instan... more The impact of cardiac dysfunction on the liver is known as cardiac hepatopathy. In certain instances this can result in significant hepatic fibrosis or cirrhosis. The validity of non-invasive tools to assess hepatic fibrosis, such as FibroScan(®) which measures liver stiffness (LSM), has not been established in this setting. We examined the impact of cardiac dysfunction on LSM using FibroScan(®) and the influence of volume changes on LSM. A prospective, cross-sectional study examined the use of FibroScan(®) in subjects with left-sided heart failure (LHF, n = 32), right-sided heart failure (RHF, n = 9), and acute decompensated heart failure (ADHF, n = 8). The impact of volume changes upon LSM was further examined in the ADHF group (pre- and post-diuresis) and in a haemodialysis group (HD, n = 12), pre- and post-ultrafiltration on dialysis. Compared with healthy controls [n = 55, LSM = median 4.4 (25th percentile 3.6, 75th percentile 5.1) kPa], LSM was increased in all the cardiac dysfunction subgroups [LHF, 4.7 (4.0, 8.7) kPa, P = 0.04; RHF, 9.7 (5.0, 10.8) kPa, P < 0.001; ADHF, 11.2 (6.7, 14.3) kPa, P < 0.001]. Alteration in volume status via diuresis did not change the baseline LSM in ADHF [11.2 (6.7, 14.3) to 9.5 (7.3, 21.6) kPa, P > 0.05] with mean diuresis 5051 ± 1585 mL, or ultrafiltration in HD [6.0 (3.6, 5.1) vs. 5.7 (4.8, 7.0) kPa, P > 0.05] with mean diuresis 1962 ± 233 mL. Our findings support the concept of increased LSM in the cardiac failure population. LSM was not altered to a statistically significant level with acute volume changes.
Bookmarks Related papers MentionsView impact
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998
The timing of referral and listing for lung transplantation in adults with cystic fibrosis is inf... more The timing of referral and listing for lung transplantation in adults with cystic fibrosis is influenced by many factors including pulmonary function, body mass index (BMI), sex, and patient and physician choice. This study aimed to analyze the effect of these variables on waiting list and postoperative mortality rates. In particular, low BMI is suggested to portend a poor outcome after transplantation. All patients with cystic fibrosis referred to our institution (n = 92) between 1989 and 1996 were reviewed, and the effect on survival of BMI, sex, and other covariates was analyzed by use of Cox proportional hazards regression. Forty-five transplantations were undertaken with a mean waiting time of 226 days (range 1 to 678). Fifteen of the 62 listed patients died before transplantation with a mean time to death of 160 days (range 8 to 533). Fifteen patients died after transplantation. BMI at the time of listing predicted waiting list mortality (P < .05). Female sex tended to incr...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
The Journal of Heart and Lung Transplantation, 2007
Bookmarks Related papers MentionsView impact
The Journal of Heart and Lung Transplantation, 2007
Bookmarks Related papers MentionsView impact
The Journal of Heart and Lung Transplantation, 2012
Bookmarks Related papers MentionsView impact
The Journal of Heart and Lung Transplantation, 2014
Bookmarks Related papers MentionsView impact
The Journal of Heart and Lung Transplantation, 2013
Bookmarks Related papers MentionsView impact
European Respiratory Journal, 2002
Bookmarks Related papers MentionsView impact
American Journal of Respiratory and Critical Care Medicine, 1998
Bookmarks Related papers MentionsView impact
American Journal of Respiratory and Critical Care Medicine, 1999
Bookmarks Related papers MentionsView impact
The Journal of Heart and Lung Transplantation, 2011
Bookmarks Related papers MentionsView impact
Respiratory medicine case reports, 2017
Bronchoscopic Lung Volume Reduction (BLVR) and Surgical Lung Volume Reduction (SLVR) and are two ... more Bronchoscopic Lung Volume Reduction (BLVR) and Surgical Lung Volume Reduction (SLVR) and are two different approaches used to remodel severely emphysematous lungs to improve lung function and quality-of-life. We present a case initially referred for lung transplantation, where sequential left upper lobe BLVR and 7 years later right upper lobe SLVR, providing enduring physiological and functional improvement. The potential for sustained benefit via sequential unilateral lung volume reduction is under-appreciated.
Bookmarks Related papers MentionsView impact
The Annals of thoracic surgery, 2016
After lung transplantation, pulmonary vein thrombosis is a rare, potentially life-threatening adv... more After lung transplantation, pulmonary vein thrombosis is a rare, potentially life-threatening adverse event arising at the pulmonary venous anastomosis that typically occurs early and presents as graft failure and hemodynamic compromise with an associated mortality of up to 40%. The incidence, presentation, outcomes, and treatment of late pulmonary vein thrombosis remain poorly defined. Management options include anticoagulant agents for asymptomatic clots, and thrombolytic agents or surgical thrombectomy for hemodynamically significant clots. We present a rare case highlighting a delayed presentation of pulmonary vein thrombosis occurring longer than 2 weeks after lung transplantation and manifesting clinically as graft failure secondary to refractory pulmonary edema. The patient was treated successfully with surgical thrombectomy and remains well. We recommend a high index of suspicion of pulmonary vein thrombosis when graft failure after lung transplantation occurs and is not res...
Bookmarks Related papers MentionsView impact
The Medical journal of Australia, Jan 19, 2016
Pulmonary arterial hypertension (PAH) is a rare disease with a poor prognosis if not treated. Pha... more Pulmonary arterial hypertension (PAH) is a rare disease with a poor prognosis if not treated. Pharmacological treatment options for PAH have increased significantly over the past 10 years, with availability of intravenous, oral and inhaled drugs targeting the nitric oxide, endothelin and prostacyclin pathways. Treatment with these therapies in specialised pulmonary hypertension centres has resulted in reductions in patient symptoms, disease progression and mortality, and improved exercise capacity. Recognition of chronic thromboembolic pulmonary hypertension is important, as this cause of pulmonary hypertension may be amenable to surgical treatment. Several new oral drugs, including macitentan, riociguat and selexipag, some of which have novel modes of action, and the use of combinations of PAH drugs have recently been shown to be beneficial in treating PAH and are likely to change treatment for this condition in the future.
Bookmarks Related papers MentionsView impact
Uploads
Papers by Trevor Williams